Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1974 Mar;120(3):183–188.

Coma, Hyperthermia and Bleeding Associated with Massive LSD Overdose

A Report of Eight Cases

John C Klock 1,2,3, Udo Boerner 1,2,3, Charles E Becker 1,2,3
PMCID: PMC1129381  PMID: 4816396

Abstract

Eight patients were seen within 15 minutes of intranasal self-administration of large amounts of pure D-lysergic acid diethylamide (LSD) tartrate powder. Emesis and collapse occurred along with signs of sympathetic overactivity, hyperthermia, coma and respiratory arrest. Mild generalized bleeding occurred in several patients and evidence of platelet dysfunction was present in all. Serum and gastric concentrations of LSD tartrate ranged from 2.1 to 26 nanograms per ml and 1,000 to 7,000 μg per 100 ml, respectively. With supportive care, all patients recovered. Massive LSD overdose in man is life-threatening and produces striking and distinctive manifestations.

Full text

PDF
183

Images in this article

184Figure 1.
on p.184

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGHAJANIAN G. K., BING O. H. PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS. Clin Pharmacol Ther. 1964 Sep-Oct;5:611–614. doi: 10.1002/cpt196455611. [DOI] [PubMed] [Google Scholar]
  2. Aledort L. M., Niemetz J. Dissociation of platelet aggregation from clot retraction, potassium loss, and adenosine triphosphatase activity. Proc Soc Exp Biol Med. 1968 Jul;128(3):658–661. doi: 10.3181/00379727-128-33091. [DOI] [PubMed] [Google Scholar]
  3. Andersen D. L. Identification of LSD and other indole alkaloids by ultraviolet degradation product. J Chromatogr. 1969 May 20;41(3):491–493. doi: 10.1016/0021-9673(64)80175-8. [DOI] [PubMed] [Google Scholar]
  4. Andén N. E., Corrodi H., Fuxe K., Hökfelt T. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br J Pharmacol. 1968 Sep;34(1):1–7. doi: 10.1111/j.1476-5381.1968.tb07943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Behnke O. Effects of some chemicals on blood platelet microtubules, platelet shape and some platelet functions in vitro. Scand J Haematol. 1970;7(2):123–140. doi: 10.1111/j.1600-0609.1970.tb01878.x. [DOI] [PubMed] [Google Scholar]
  6. Boakes R. J., Bradley P. B., Briggs I., Dray A. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25. Br J Pharmacol. 1970 Oct;40(2):202–218. doi: 10.1111/j.1476-5381.1970.tb09914.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brawley P., Duffield J. C. The pharmacology of hallucinogens. Pharmacol Rev. 1972 Mar;24(1):31–66. [PubMed] [Google Scholar]
  8. FORRER G. R., GOLDNER R. D. Experimental physiological studies with lysergic acid diethylamide (LSD-25). AMA Arch Neurol Psychiatry. 1951 May;65(5):581–588. doi: 10.1001/archneurpsyc.1951.02320050038004. [DOI] [PubMed] [Google Scholar]
  9. Fish F., Wilson W. D. Excretion of cocaine and its metabolites in man. J Pharm Pharmacol. 1969 Dec;21(Suppl):135S+–135S+. doi: 10.1111/j.2042-7158.1969.tb08363.x. [DOI] [PubMed] [Google Scholar]
  10. Friedman S. A., Hirsch S. E. Extreme hyperthermia after LSD ingestion. JAMA. 1971 Sep 13;217(11):1549–1550. [PubMed] [Google Scholar]
  11. HOFFER A. D-LYSERGIC ACID DIETHYLAMIDE (LSD): A REVIEW OF ITS PRESENT STATUS. Clin Pharmacol Ther. 1965 Mar-Apr;6:183–255. doi: 10.1002/cpt196562183. [DOI] [PubMed] [Google Scholar]
  12. Louria D. B. Lysergic acid diethylamide. N Engl J Med. 1968 Feb 22;278(8):435–438. doi: 10.1056/NEJM196802222780806. [DOI] [PubMed] [Google Scholar]
  13. Martin W. R., Sloan J. W. Effects of infused tryptamine in man. Psychopharmacologia. 1970;18(3):231–237. doi: 10.1007/BF00412669. [DOI] [PubMed] [Google Scholar]
  14. Michal F. D-receptor for serotonin on blood platelets. Nature. 1969 Mar 29;221(5187):1253–1254. doi: 10.1038/2211253a0. [DOI] [PubMed] [Google Scholar]
  15. Mulé S. J. Identification of narcotics, barbiturates, amphetamines, tranquilizers and psychotomimetics in human urine. J Chromatogr. 1969 Feb 11;39(3):302–311. doi: 10.1016/s0021-9673(01)98015-x. [DOI] [PubMed] [Google Scholar]
  16. RINKEL M., HYDE R. W., SOLOMON H. C., HOAGLAND H. Experimental psychiatry. II. Clinical and physio-chemical observations in experimental psychosis. Am J Psychiatry. 1955 Jun;111(12):881–895. doi: 10.1176/ajp.111.12.881. [DOI] [PubMed] [Google Scholar]
  17. Rubenstein K. E., Schneider R. S., Ullman E. F. "Homogeneous" enzyme immunoassay. A new immunochemical technique. Biochem Biophys Res Commun. 1972 May 26;47(4):846–851. doi: 10.1016/0006-291x(72)90570-0. [DOI] [PubMed] [Google Scholar]
  18. West L. J., Pierce C. M., Thomas W. D. Lysergic Acid Diethylamide: Its Effects on a Male Asiatic Elephant. Science. 1962 Dec 7;138(3545):1100–1103. doi: 10.1126/science.138.3545.1100. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES